| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.293.22.2756 |
| P698 | PubMed publication ID | 15941805 |
| P50 | author | Young Ae Kang | Q60656003 |
| BeLong Cho | Q86070955 | ||
| Young-Soo Shim | Q112998760 | ||
| P2093 | author name string | Ho Il Yoon | |
| Hye Won Lee | |||
| Jae-Joon Yim | |||
| Sung Koo Han | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| latent tuberculosis | Q4254929 | ||
| tuberculin | Q29505 | ||
| P304 | page(s) | 2756-2761 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country | |
| P478 | volume | 293 |
| Q64108128 | A Bibliometric Analysis on Tuberculosis Research of Korea from 1979 to 2017 |
| Q41372671 | A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA. |
| Q64078207 | A Feasibility Study for Diagnosis of Latent Tuberculosis Infection Using an IGRA Point-of-Care Platform in South Korea |
| Q34709566 | A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor |
| Q36864486 | A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea |
| Q38661516 | Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection. |
| Q30047515 | Allergy Diagnostic Testing: An Updated Practice Parameter |
| Q83189516 | Assessing tuberculosis transmission and virulence: the vanishing tuberculin skin test |
| Q41981689 | Choroidal tuberculoma as a presenting sign of tuberculosis. |
| Q51706009 | Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection. |
| Q41373771 | Clinical Utility of Two Interferon-gamma Release Assays on Pleural Fluid for the Diagnosis of Tuberculous Pleurisy |
| Q33866395 | Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test |
| Q33690691 | Comparing tuberculin skin test and interferon γ release assay (T-SPOT.TB) to diagnose latent tuberculosis infection in household contacts |
| Q60053836 | Comparison of IFN-γ Levels in Children with Tuberculosis Disease (TB) and Latent Tuberculosis Infection (LTBI) |
| Q24672852 | Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel |
| Q36242831 | Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting |
| Q42228060 | Comparison of Tuberculin Skin Test result and interferon gamma response to human PPD in BCG scar positive and negative children. |
| Q34325903 | Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population |
| Q35855200 | Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals |
| Q34066281 | Comparison of interferon-γ release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers |
| Q36095990 | Comparison of quantiferon test with tuberculin skin test for the detection of tuberculosis infection in children |
| Q36747473 | Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis |
| Q33895231 | Comparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients |
| Q84966012 | Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population |
| Q33303921 | Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia |
| Q35783572 | Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics |
| Q36861562 | Current issues on molecular and immunological diagnosis of tuberculosis |
| Q37431509 | Diagnosing latent tuberculosis infection in the HIV era. |
| Q30979334 | Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country |
| Q35307280 | Diagnosis and treatment of latent tuberculosis infection |
| Q37221167 | Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea |
| Q22241488 | Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? |
| Q42014010 | Diagnosis of latent tuberculosis: Can we do better? |
| Q98940152 | Diagnostic Potential of a PPE Protein Derived from Mycobacterium tuberculosis Beijing/K Strain |
| Q37156737 | Differences in tuberculin reactivity as determined in a veterans administration employee health screening program |
| Q33599396 | Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil. |
| Q42413222 | Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation |
| Q26780382 | Do the tuberculin skin test and the QuantiFERON-TB Gold in-tube test agree in detecting latent tuberculosis among high-risk contacts? A systematic review and meta-analysis |
| Q46493177 | ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease |
| Q37469604 | Effect of prolonged incubation time on results of the QuantiFERON TB gold in-tube assay for diagnosis of latent tuberculosis infection |
| Q82847945 | Evaluation of a tuberculosis whole-blood interferon-γ chemiluminescent immunoassay among Chinese military recruits |
| Q48014688 | Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis |
| Q57214423 | Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South Korea |
| Q47340142 | Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis |
| Q33555208 | Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects |
| Q36777647 | Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals |
| Q34314999 | Fiberoptic bronchoscopy for the rapid diagnosis of smear-negative pulmonary tuberculosis |
| Q33301317 | Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis |
| Q83179093 | High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test |
| Q33454961 | High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area |
| Q49771060 | Household tuberculosis contact investigation in a tuberculosis-prevalent country: Are the tuberculin skin test and interferon-gamma release assay enough in elderly contacts? |
| Q43466707 | IGRAs--the gateway to T cell based TB diagnosis |
| Q33358065 | Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. |
| Q34649281 | Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection |
| Q47643684 | Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. |
| Q35596387 | Interferon gamma release assay compared with the tuberculin skin test for latent tuberculosis detection in pregnancy |
| Q44405791 | Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants |
| Q41942801 | Interferon-γ Enzyme-Linked Immunospot Assay in Patients with Tuberculosis and Healthy Adults. |
| Q90458634 | Is latent tuberculosis infection challenging in Iranian health care workers? A systematic review and meta-analysis |
| Q35116232 | Latent TB infection diagnosis in population exposed to TB subjects in close and poor ventilated high TB endemic zone in India |
| Q34872252 | Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test |
| Q41483994 | Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study |
| Q64131657 | Latent tuberculosis infections in hard-to-reach drug using population-detection, prevention and control |
| Q33411543 | Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis |
| Q45387141 | Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea |
| Q30907264 | New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response |
| Q81565307 | Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children |
| Q33518054 | Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population |
| Q81250867 | Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment |
| Q37598830 | Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls |
| Q33247785 | Prevalence and predictors of tuberculin skin positivity in Hellenic Army recruits |
| Q33497330 | Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam. |
| Q57211295 | Prevalence and risk factors of latent tuberculosis among Korean healthcare workers using whole-blood interferon-γ release assay |
| Q34552676 | Prevalence and risk factors of latent tuberculosis infection among health care workers in Malaysia |
| Q37090046 | Prevalence of Latent Tuberculosis Infection among Health Care Workers in South Korea: A Multicenter Study. |
| Q41372791 | Prevalence of Latent Tuberculosis Infection among Medical Students in South Korea |
| Q34309664 | Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy. |
| Q37436425 | Prevalence of latent tuberculosis infection in healthcare workers at a hospital in Naples, Italy, a low-incidence country |
| Q26739001 | Pulmonary Tuberculosis Diagnosis: Where We Are? |
| Q47448449 | Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Guérin therapy |
| Q34351266 | Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa |
| Q36375791 | Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs) |
| Q34386405 | Recent advances in testing for latent TB. |
| Q80759233 | Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis |
| Q36497683 | Reproducibility of QuantiFERON-TB gold in-tube assay |
| Q34064827 | Results of five-year systematic screening for latent tuberculosis infection in healthcare workers in Portugal |
| Q33869437 | Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa |
| Q42251206 | Risk factors for false-negative results of T-SPOT.TB and tuberculin skin test in extrapulmonary tuberculosis |
| Q88653928 | Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test? |
| Q33334644 | Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test |
| Q51212229 | Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. |
| Q54241389 | Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test. |
| Q35073163 | Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis |
| Q46655776 | Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort |
| Q33719971 | Serial interferon-gamma release assays during treatment of active tuberculosis in young adults |
| Q35300301 | Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents |
| Q58713484 | Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis |
| Q22241138 | Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update |
| Q33494752 | T-cell-based diagnosis of tuberculosis infection in children in Lithuania: a country of high incidence despite a high coverage with bacille Calmette-Guerin vaccination |
| Q33625365 | TB among health personnel of the public sector in Burundi: frequency and risk factors |
| Q47660164 | Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study |
| Q36205497 | The Prevalence Rate of Tuberculin Skin Test Positive by Contacts Group to Predict the Development of Active Tuberculosis After School Outbreaks. |
| Q35895230 | The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda |
| Q33875831 | The clinical utility of tuberculin skin test and interferon-γ release assay in the diagnosis of active tuberculosis among young adults: a prospective observational study |
| Q46718684 | The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients |
| Q35028459 | The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers. |
| Q92627208 | The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus |
| Q33686696 | The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in Korea |
| Q51758287 | The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs. |
| Q46846947 | Treatment of neuro-ophthalmologic manifestations of tuberculosis. |
| Q48301850 | Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07. |
| Q38906500 | Tuberculin Skin Test among 1,424 Healthy Employees in Chaharmahal Province, Iran. |
| Q37668841 | Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants |
| Q37413003 | Tuberculin skin test. How to optimise? |
| Q33591688 | Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants |
| Q39911964 | Tuberculosis - Risk of continued transmission in healthcare workers |
| Q36515625 | Tuberculosis and nontuberculous mycobacterial infections in older adults |
| Q45401374 | Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease |
| Q41871686 | Tuberculosis contact investigation using interferon-gamma release assay with chest x-ray and computed tomography |
| Q34691242 | Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. |
| Q36647175 | Tuberculosis in children: an update |
| Q33860906 | Tuberculosis infection in rural labor migrants in Shenzhen, China: Emerging challenge to tuberculosis control during urbanization |
| Q36856010 | Tuberculosis: diagnostics |
| Q34516560 | Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study |
| Q57816356 | Use of QuantiFERON-TB Gold to determine the aetiology of idiopathic erythema induratum: A case report |
| Q34046364 | Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis |
| Q37708183 | Whole blood interferon-γ release assay is insufficient for the diagnosis of sputum smear negative pulmonary tuberculosis |
| Q80059527 | [Interferon-gamma release assays in tuberculosis diagnostics] |
| Q80237437 | [New blood tests for diagnosis of infection with Mycobacterium tuberculosis] |
| Q53800517 | [New immunological tests in the diagnosis of tuberculosis] |
| Q84781603 | [Pulmonary and pleural tuberculosis in the elderly] |
Search more.